logo

For the Inventor, By the Inventor

Tokushima, Japan

Yasuo Oshiro

USPTO Granted Patents = 19

Average Co-Inventor Count = 3.7

ph-index = 9

Forward Citations = 375(Granted Patents)


Company Filing History:

goldMedal19 out of 846 
 
Otsuka Pharmaceutical Company, Limited
 patents

Years Active: 1979-2020

Loading Chart...
19 patents (USPTO):Explore Patents
1. RE48059 - Piperazine-substituted benzothiophenes for treatment of mental disorders (2020-06-22),
2. 6133264 - Carbostyril derivatives for inhibiting skin erythema and/or skin (2000-10-17),
3. 5786367 - Cyclic amide derivatives (1998-07-28),
4. 5656633 - Carbostyril derivatives and pharmaceutical compositions containing the (1997-08-12),
5. 5556857 - Disturbance-of-consciousness improving agent (1996-09-17),
6. 5242919 - 2,3-dihydro-1H-indene derivatives (1993-09-07),
7. 5055474 - 2,3-dihydro-1H-indene derivatives and their use as pharmaceutical agents (1991-10-08),
8. 5017724 - Hydrofluorene derivatives (1991-05-21),
9. 5006528 - Carbostyril derivatives (1991-04-09),
10. 4914094 - Method for treating hypoxia (1990-04-03),
11. 4895847 - 2,3-dihydro-1H-indene derivatives (1990-01-23),
12. 4831053 - Composition for prophylaxis and therapy of hepatitis (1989-05-16),
13. 4824840 - Carbostyril derivatives and pharmaceutical preparations containing same (1989-04-25),
14. 4792628 - Indane derivatives and salts thereof (1988-12-20),
15. 4788130 - 1-amino-2,3-dihydro-1H-indene compounds (1988-11-29),

Title: **Yasuo Oshiro: Innovator in Pharmaceutical Patents**

Introduction

Yasuo Oshiro is a prominent inventor based in Tokushima, Japan, recognized for his significant contributions to the field of pharmaceuticals. With a substantial portfolio of 19 patents, he has made impactful advancements in the treatment of mental disorders and skin conditions.

Latest Patents

One of his latest innovations includes piperazine-substituted benzothiophenes, which present a novel approach for treating mental disorders. This invention involves a heterocyclic compound represented by the general formula (1), which showcases a wide treatment spectrum for various central nervous system disorders, along with minimal side effects and high safety. Another noteworthy patent features carbostyril derivatives aimed at inhibiting skin erythema, showcasing his versatility and dedication to improving health outcomes.

Career Highlights

Yasuo Oshiro is affiliated with Otsuka Pharmaceutical Company, Limited, where he utilizes his expertise to drive innovation. His work has not only advanced medical treatments but also placed him at the forefront of pharmaceutical research and development.

Collaborations

Throughout his career, Yasuo has had the opportunity to collaborate with talented colleagues such as Kazuyuki Nakagawa and Tatsuyoshi Tanaka. These partnerships highlight the importance of teamwork in fostering breakthroughs within the pharmaceutical industry.

Conclusion

In summary, Yasuo Oshiro's contributions to the field of pharmaceuticals through his patents and collaborative efforts have made a significant impact on health and wellness. His innovative spirit and dedication to research continue to inspire advancements that benefit society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…